City of Hope Expands Its High-Quality Oncology Services to Additional Sites Across Southern California

April 2, 2018
Letisia Marquez
[email protected]
The US Oncology Network
[email protected]
Partnership with Vantage Oncology, affiliate of The US Oncology Network, provides patients with access to enhanced radiation therapy services
DUARTE, Calif. — City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, today announced it is adding nine radiation oncology sites to City of Hope Medical Foundation through a joint venture with Vantage Oncology, a leading national radiation oncology network that is part of The US Oncology Network. The partnership will make significant enhancements to the sites’ technology, equipment and facilities to improve the overall patient experience.

“Nearly 50 percent of cancer patients will receive radiation therapy at some point in their treatment,” said Harlan Levine, M.D., president of strategy and business ventures for City of Hope. “The addition of these new sites makes City of Hope one of the largest radiation oncology providers in Southern California, driving our goal of delivering high quality care to more people in their own communities.”
City of Hope will now provide radiation oncology services at practice sites in Glendale, Mission Hills, Riverside, San Bernardino, Santa Clarita, Sherman Oaks, Temecula, West Hills and Wildomar in addition to its sites in Duarte, Antelope Valley, Arcadia, Corona and South Pasadena. The US Oncology Network will provide operational support and certain management services to these new sites through the joint venture.

Valley Radiotherapy Associates (VRA) radiation oncologists will join City of Hope Medical Group, and continue to provide radiation oncology services at the nine sites and at Providence Saint John’s Health Center (Santa Monica), Providence Saint Joseph Medical Center (Burbank), St. Joseph Hospital Orange and St. Jude Medical Center (Fullerton). An integral part of these communities, these oncologists will continue to bring their in-depth understanding of coordinated community oncology care to patients, while embracing City of Hope’s philosophy of compassionate, patient-centered treatment and accessing City of Hope’s translational clinical research and precision medicine expertise.

“I founded VRA over three decades ago with a commitment to excellence in clinical cancer treatment, service delivery and technical acumen, and City of Hope shares that commitment,” said Leslie E. Botnick, M.D., who joins City of Hope as senior director of Radiation Oncology at the new radiation oncology sites. “We are excited about the expanded opportunities this alignment will provide to our patients and physicians.”

The nine sites are the most recent additions to City of Hope’s growing system of community practice sites. City of Hope’s clinical network has now grown to 29 locations throughout Southern California, all of which extend the institution’s reach by bringing premier care to patients closer to their homes.

“We are truly delighted to welcome these physicians to the City of Hope family, and to partner with Vantage Oncology to bring new advances in radiotherapy to the communities we serve,” said Vincent Jensen, chief executive, City of Hope Medical Foundation. “This expansion of City of Hope’s reach also provides further opportunity to bring other critical oncology services to communities in need.”
About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as one of only 49 comprehensive cancer centers, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the world. City of Hope is located in Duarte, California, just northeast of Los Angeles, with community practice sites throughout Southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation, diabetes and numerous breakthrough cancer drugs based on technology developed at the institution.
For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.
# # #
About The US Oncology Network
Every day, The US Oncology Network (The Network) helps more than 1,400 independent physicians deliver value-based, integrated care for patients—close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides doctors with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson Specialty Health. This collaboration allows the doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Together, The Network and its affiliated physicians are committed to the success of independent practices, everywhere. For more information, visit
About Valley Radiotherapy Associates Medical Group, Inc.
Valley Radiotherapy Associates Medical Group, Inc. (VRA) was founded in 1983 to provide advanced radiation therapy services to the communities of Southern California. VRA has distinguished itself for more than three decades as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, service delivery and technical acumen to develop new cancer treatment programs.
# # #